Innovision Limited Reports No Deviation in IPO Fund Utilization for Q1 FY27
Innovision Limited confirms no deviation in IPO fund utilization for the quarter ended June 30, 2026. Funds raised via IPO on March 23, 2026, were used for debt repayment, working capital, and general corporate purposes as planned. Monitoring agency CRISIL Ratings Limited reviewed the utilization.
This is a standard compliance filing and does not introduce new material information that would significantly impact the company's stock or operations.
The announcement is a routine regulatory filing confirming no deviations in fund utilization, which is a neutral event.
Innovision Limited has submitted a statement of deviations and variations under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2026. The company reported no significant deviation or variation in the utilization of funds raised through its Initial Public Offer (IPO).
The IPO, which raised ₹2,550 million (gross proceeds) and ₹2,097.99 million (net proceeds) on March 23, 2026, had its funds allocated across three main objects: repayment of borrowings, funding working capital requirements, and general corporate purposes.
For the repayment of borrowings, the entire ₹510.00 million allocated was fully utilized during the quarter ended March 31, 2026. Funding working capital requirements saw an allocation of ₹1,190.00 million, with ₹161.54 million utilized towards expenses like EPFO, ESCI, GST, and a security deposit for the Khiriya Fee Plaza contract with NHAI. General corporate purposes, allocated ₹397.99 million, had ₹1.36 million utilized towards bank charges for issuing a bank guarantee.
The statement, filed for the year ended June 30, 2026, was monitored by CRISIL Ratings Limited. The company confirmed that any deviations, if present, were not pursuant to a change in terms of a contract or objects requiring shareholder approval.
What to do with a filing like this
Innovision Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Innovision Limited. Read the original for the full detail.